المؤلفون: Dello Russo, Cinzia, Navarra, Pierluigi

المساهمون: Dello Russo, Cinzia, Navarra, Pierluigi

مصطلحات موضوعية: BICR, ORR, PFS, local investigators, objective response rate, oncology, pharmacotherapy, progression-free survival, Settore BIO/14 - FARMACOLOGIA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35652050; info:eu-repo/semantics/altIdentifier/wos/WOS:000804712500001; volume:13; issue:May; firstpage:1; lastpage:17; numberofpages:17; issueyear:2022; journal:FRONTIERS IN PHARMACOLOGY; https://hdl.handle.net/10807/210463Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85131418679

الإتاحة: https://doi.org/10.3389/fphar.2022.858354Test
https://hdl.handle.net/10807/210463Test

المؤلفون: Cinzia Dello Russo, Pierluigi Navarra

مصطلحات موضوعية: Pharmacology, PFS, local investigators, pharmacotherapy, ORR, Settore BIO/14 - FARMACOLOGIA, oncology, Pharmacology (medical), BICR, progression-free survival, objective response rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c0b507c6a62aba12fc600887ae30cfdTest
http://hdl.handle.net/10807/210463Test

المؤلفون: Yongping Song, Ting Liu, Donglu Zhao, Xiaobing Huang, Wei Xu, Guangxun Gao, Haiyan Yang, Jun Zhu, Jinghua Wang, Wei-Li Zhao, Qingqing Cai, Min Mao, Zhihui Zhang, Qingshu Zeng, Hongwei Xue, Kaiyang Ding, Jingyan Xu, Hang Su, Yuankai Shi, Ting Niu, Liling Zhang, Peng Liu, Hongyu Zhang, Jianzhen Shen, Lihong Liu, Huiqiang Huang, Jianfeng Zhou, Xiaojing Yan, Ru Feng, Jie Jin, Jianda Hu, Huilai Zhang, Xin Wang, Jun Ma, Huo Tan, Lugui Qiu, Bing Xu, Yu Yang, Daobin Zhou, Hui Zhou, Zhi-Xiang Shen, Ou Bai, Weiping Liu, Wenyu Li, Zhi Ming Li, Ming Hou

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)

مصطلحات موضوعية: safety, Oncology, medicine.medical_specialty, Cancer Research, medicine.medical_treatment, T cell, lymphoma, histone deacetylase inhibitors, survival, chemistry.chemical_compound, T-cell, Refractory, Chidamide, Internal medicine, medicine, peripheral, Adverse effect, Objective response, RC254-282, Original Research, Chemotherapy, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Peripheral, Lymphoma, medicine.anatomical_structure, chemistry, efficiency, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58fe4731b3498f051335b4853ed8a940Test

المؤلفون: Yan Li, Yiqi Ma, Zijun Wu, Fanxin Zeng, Bin Song, Yanrong Zhang, Jinxing Li, Su Lui, Min Wu

المصدر: Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Colorectal cancer, business.industry, overall survival, Hazard ratio, Immunology, Cancer, Microsatellite instability, colorectal cancer, Odds ratio, Publication bias, RC581-607, tumor mutation burden, medicine.disease, immune checkpoint inhibitors, Internal medicine, Meta-analysis, medicine, Biomarker (medicine), Immunology and Allergy, Systematic Review, Immunologic diseases. Allergy, business, objective response rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ac0fe2197882c3e2787f50511e57decTest

المؤلفون: Jiting Wang, Song Su, Jun Li, Yaling Li

المصدر: Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology

مصطلحات موضوعية: 0301 basic medicine, Oncology, safety, medicine.medical_specialty, Cancer Research, Combination therapy, medicine.medical_treatment, Combined use, efficacy, combination therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Clinical endpoint, Medicine, Adverse effect, Objective response, RC254-282, Chemotherapy, camrelizumab, business.industry, Rate control, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, meta-analysis, 030104 developmental biology, 030220 oncology & carcinogenesis, Meta-analysis, monotherapy, Systematic Review, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9432a16ced01940c783e88d78ab8fd8Test

المؤلفون: Wei Mao, Can Hu, Ping Hu, Guofa Yu, Yu Zhang, Shanqi Chen, Xiang-Dong Cheng, Conggang Hu, Zhiyuan Xu, Jianfa Yu, Yian Du

المصدر: Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology

مصطلحات موضوعية: safety, 0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, medicine, Pharmacology (medical), Apatinib, Objective response, Original Research, Pharmacology, Chemotherapy, business.industry, gastric cancer, lcsh:RM1-950, Cancer, Advanced gastric cancer, medicine.disease, Surgery, lcsh:Therapeutics. Pharmacology, 030104 developmental biology, Paclitaxel, chemistry, conversion surgery, Anastomotic leakage, 030220 oncology & carcinogenesis, unresectable abdominal neoplasms, Gastrectomy, business, apatinib

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed58febf005095e315b56e7d9b9a771Test
https://doi.org/10.3389/fphar.2021.642511Test

المؤلفون: Jindi Han, Jian Fang, Ziran Zhang, Jie Zhang, Jun Nie, Sen Han, Xiangjuan Ma, Yang Wang, Di Wu, Weiheng Hu, Jieran Long, Xiaoling Chen, Guangming Tian, Ling Dai

المصدر: Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, survival, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Immune system, Internal medicine, PD-L1, medicine, real-world evidence, Lung cancer, Adverse effect, non-small cell lung cancer, Original Research, biology, business.industry, Cancer, Retrospective cohort study, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, adverse events, objective response, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, immunotherapy, Non small cell, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d28bdde7d0a4e760545ea2ab3d9045dTest
https://doi.org/10.3389/fonc.2021.607531Test

المؤلفون: Jin Kang, Xu-Chao Zhang, Hua-Jun Chen, Wen-Zhao Zhong, Yang Xu, Jian Su, Qing Zhou, Hai-Yan Tu, Zhen Wang, Chong-Rui Xu, Xue-Ning Yang, Zhi-Hong Chen, Xue Wu, Xian Zhang, Yang Shao, Yi-Long Wu, Jin-Ji Yang

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)

مصطلحات موضوعية: Cancer Research, complex ALK fusions, Crizotinib, business.industry, Treatment outcome, EML4-ALK, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Oncology, hemic and lymphatic diseases, non-canonical ALK fusion, tyrosine kinase inhibitors, medicine, Cancer research, Anaplastic lymphoma kinase, In patient, Non small cell, Lung cancer, business, Tyrosine kinase, Objective response, non-small cell lung cancer, medicine.drug, Original Research

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49c5a22ac5f9336e6f39a6b3378f8a64Test

المؤلفون: Pil Soo Sung, Moon Hyung Choi, Hyun Yang, Soon Kyu Lee, Ho Jong Chun, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Joon-Il Choi, Young Joon Lee, Si Hyun Bae

المصدر: Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Urology, hepatic arterial infusion chemotherapy, lcsh:RC254-282, magnetic resonance, 03 medical and health sciences, 0302 clinical medicine, medicine, Effective diffusion coefficient, diffusion restriction, Stage (cooking), Original Research, oncology_oncogenics, Cisplatin, medicine.diagnostic_test, business.industry, Magnetic resonance imaging, hepatocellular carcinoma, Odds ratio, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, BCLC Stage, body regions, objective response, Oncology, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, 030211 gastroenterology & hepatology, Liver cancer, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c6fb94e424387ca0ade630d7b8ef10Test
https://doi.org/10.3389/fonc.2020.600233Test

المؤلفون: Yi Yang, Gang Jin, Yao Pang, Yijie Huang, Wenhao Wang, Hongyi Zhang, Guangxin Tuo, Peng Wu, Zequan Wang, Zijiang Zhu

المصدر: Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology

مصطلحات موضوعية: safety, 0301 basic medicine, Oncology, medicine.medical_specialty, Combination therapy, efficacy, Ipilimumab, Cochrane Library, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, advanced cancer, Pharmacology (medical), ipilimumab, Adverse effect, Objective response, nivolumab, Pharmacology, business.industry, lcsh:RM1-950, Advanced cancer, lcsh:Therapeutics. Pharmacology, 030104 developmental biology, 030220 oncology & carcinogenesis, Meta-analysis, combination immunotherapy, Systematic Review, Nivolumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe51e50ff2222d1e62abc24a131c22cTest
https://doi.org/10.3389/fphar.2020.00040Test